B. , A. Kastrisis, E. Bamia, C. Moulopoulos, and L. A. , Osteonecrosis of the jaw in cancer after treatment with bisphosphonates : incidence and risk factors

B. , A. Blandamura, S. Lokmic, and Z. , Bisphosphonate associated jawbone osteonecrosis: A correlation between imaging techniques and histopathology

B. , M. Vali, R. Waldenberger, P. Fitz, F. Nader et al., Detection of bone metastases in patients with prostate cancer by 18 F fluorocholine and 18 F fluoride PET-CT: a comparative study

J. Beltran, O. Opsha, and . Mr, MR Imaging of the Hip: Osseous Lesions, Magnetic Resonance Imaging Clinics of North America, vol.13, issue.4
DOI : 10.1016/j.mric.2005.08.011

B. , G. M. Park-holohan-s, G. J. Cook, and I. Fogelman, Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate

B. Phosphore, ou quand on oublie les leçons du passé, Rev Med Suisse, vol.12, pp.7-13, 2006.

C. , G. Goss, A. N. Doeke, and C. , Bisphosphonates and avascular necrosis of the jaws: a possible association

C. , G. J. Fogelman, and I. , The role of positron emission tomography in skeletal disease

G. J. Cook and P. Pet, CT imaging of skeletal metastases, Cancer Imaging, vol.10, pp.1-8, 2010.

C. , A. Santoro, N. Cantatore, and F. , Extra-skeletal effects of bisphosphonates

C. , S. ;. Farooki, and A. , Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancerinvolving the bone Ann, N.Y. Acad. Sci, pp.80-87, 1218.

D. , M. A. Kastritis, E. Agnagnotopoulos, A. Melakopoulos, and I. , Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates : evidence of increased risk after treatment with zoledronic acid

D. , J. P. Goldwasser, and F. , Savoir prescrire l'acide zolédronique (ZOMETA®)

P. C. Physique-et-biophysique, M: Bases de l'utilisation médicale et biologique des radiations

. Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukemia Group, Lancet, vol.340, pp.1092-1052, 1992.

L. , C. Y. Suzuki, and J. B. , CTX biochemical marker of bone metabolism. is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study, Implant. Dent, vol.19, pp.29-38, 2010.

J. H. Lin, Bisphosphonates: A review of their pharmacokinetic properties, Bone, vol.18, issue.2
DOI : 10.1016/8756-3282(95)00445-9

L. , J. C. O-'ryan, F. S. Gordon, N. P. Yang, J. Hui et al., Predicting risk of osteonecrosis of the jaw with oral bisphosphonate exposure (PROBE) investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure

M. , M. D. Obeid, and G. , Osteonecrosis of the Maxilla in a Patient with a History of Bisphosphonate therapy

N. Generale, R. Actes-professionnels-http, . Woo, . Karen, T. Hande-;-jeffrey et al., ameli.fr/accueil-de-la-ccam/trouver-un-acte/par-code.php 100, NOOPUR

P. , G. Richardson-;-sonia, and V. , Radiographic, and Biochemical Characterization of MultipleMyeloma Patients with Osteonecrosis of the, Jaw Clin Cancer Res, vol.14, pp.2387-2395, 2008.

T. , T. Kilian, K. Timm, and . Steiner-;, A Valuable Marker for Osteonecrosis Characterization and Therapy J Oral Maxillofac Surg, pp.125-129, 2010.

J. Potts, Parathyroid hormone: past and present, Journal of Endocrinology, vol.187, issue.3
DOI : 10.1677/joe.1.06057

P. M. Purcell and I. W. Boiyd, Bisphosphonates and osteonecrosis of the jaw

R. , M. J. Gordon, S. Benford, and H. L. , Cellular and molecular mechanisms of actions of bisphosphonates

R. , S. L. Mehrota, B. Rosenberg, T. J. Engroff, and S. L. , Osteonecrosis of the jaws associated with use of bisphosphonates: a review of 63 cases

R. , S. L. Mehrota, and B. , Ten years of Alendronate. Treatment for osteoporosis in postmenopausal women

S. , M. J. Eastel, R. Grundberg, and C. M. , Biochemical markers of bone metabolism. of Principles of, Bone Biology, 2002.

M. Seibel, Biochemicalmarkers of bone turnover. Part1: biochemistry and variability

C. Shipman, M. J. Rogers, and J. Apperley, Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity, British Journal of Haematology, vol.98, issue.3
DOI : 10.1046/j.1365-2141.1997.2713086.x

M. , F. Eleftherios, V. , N. Emeka, and N. , Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study Clin Oral Invest, pp.311-317, 2010.

T. , Y. Ikeo, T. Nakajima, M. Miki, T. Fujita et al., A pilot case?control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw Osteoporos Int, pp.815-825, 2010.

T. , W. A. Buytaert, P. M. Berneman, and Z. N. , Reduction of visible bone metastases by clodronate therapy in breast cancer, Eur J Gynaecol Oncol, vol.22, pp.215-216, 2001.

T. , N. Sheehy, N. Bae, E. H. Friedland, B. Lerman et al., Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws Oral Diseases, pp.88-92, 2009.

G. Van-der-pluijm, H. Vloedgraven, and E. Van-beek, Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro., Journal of Clinical Investigation, vol.98, issue.3
DOI : 10.1172/JCI118841

V. , T. Rheinfelden, and R. , Ostéochimionécroses associées aux bisphosphonates: ce n'est que la pointe de l'iceberg! Schweiz Monatsschr Zahnmed, pp.586-590, 2006.

V. , P. Manfredi, M. Merigo, and E. , Surgical approach with ER:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)

W. , J. Goodger, N. M. Pogrel, and M. A. , Osteonecrosis of the jaws associated with cancer chemotherapy

S. B. Woo, J. W. Hellstein, and J. Kalmar, Narrative review: Bisphosphonates and osteonecrosis of the jaws

W. , A. Eisenmenger, G. Hoffmann, M. Czerny, and C. , Osteonecrosis of the jaws and bisphosphonates treatment in cancer patients

Y. , K. , K. , O. , Y. Walter et al., Correlation Between Serum C-Terminal Cross-Linking Telopeptide of Type I Collagen and Staging of Oral Bisphosphonate-Related Osteonecrosis of the Jaws, Journal of Oral and Maxillofacial Surgery, vol.67, issue.12, pp.2644-2648, 2009.
DOI : 10.1016/j.joms.2009.04.067